Risk of Malignancy in Resected Cystic Tumors of the Pancreas ≤3 cm in Size: Is it Safe to Observe Asymptomatic Patients? A Multi-institutional Report

作者: C. J. Lee , J. Scheiman , M. A. Anderson , O. J. Hines , H. A. Reber

DOI: 10.1007/S11605-007-0381-Y

关键词:

摘要: Recent international consensus guidelines propose that cystic pancreatic tumors less than 3 cm in size asymptomatic patients with no radiographic features concerning for malignancy are safe to observe; however, there is little published data support this recommendation. The purpose of study was determine the prevalence group using resection databases from five high-volume centers assess appropriateness these guidelines. All resections performed neoplasms ≤3 were evaluated over time period 1998–2006. One hundred sixty-six cases identified, and clinical, radiographic, pathological reviewed. correlation age, gender, symptoms (abdominal pain, nausea vomiting, jaundice, presence pancreatitis, unexplained weight loss, anorexia), suggestive by either computed tomography, magnetic resonance imaging, or endoscopic ultrasound (presence solid component, lymphadenopathy, dilated main duct common bile duct), assessed univariate multivariate analysis. Among 166 cm, 135 benign [38 serous cystadenomas, 35 mucinous neoplasms, 60 intraductal papillary (IPMN), 1 tumor, islet cell tumor], whereas 31 malignant (14 adenocarcinomas 13 invasive carcinomas 4 situ arising setting IPMN). A greater incidence seen female (99/166, 60%). Gender a predictor pathology, male having higher (19/67, 28%) compared (12/99, 12%; p < 0.02). Older age associated (mean 67 years disease vs 62 lesions (p 0.05). majority symptomatic (28/31, 90%). Symptoms correlated included jaundice 0.001), loss 0.003), anorexia Radiographic component 0.0001), dilation = 0.002), lymphadenopathy 0.002). Twenty-seven 31(87%) had at least one feature malignancy. Forty-five (27%) identified as neoplasms. but three (6.6%) disease. Of features, out 30 (3.3%) (carcinoma side branch Malignancy older (jaundice, (solid dilation, lymphadenopathy). displayed discernable who underwent resection, occult 3.3%. This suggests small have low risk can be selective may appropriate.

参考文章(26)
Michael G. Sarr, Herschel A. Carpenter, Lawrence P. Prabhakar, Todd F. Orchard, Steven Hughes, Jon A. van Heerden, Eugene P. DiMagno, Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas. Can one reliably differentiate benign from malignant (or premalignant) neoplasms Annals of Surgery. ,vol. 231, pp. 205- 212 ,(2000) , 10.1097/00000658-200002000-00009
Kristine S. Spinelli, Travis E. Fromwiller, Roger A. Daniel, James M. Kiely, Attila Nakeeb, Richard A. Komorowski, Stuart D. Wilson, Henry A. Pitt, Cystic pancreatic neoplasms: observe or operate. Annals of Surgery. ,vol. 239, pp. 651- 659 ,(2004) , 10.1097/01.SLA.0000124299.57430.CE
Taylor A Sohn, Charles J Yeo, John L Cameron, Christine A Iacobuzio-Donahue, Ralph H Hruban, Keith D Lillemoe, None, Intraductal Papillary Mucinous Neoplasms of the Pancreas: An Increasingly Recognized Clinicopathologic Entity Annals of Surgery. ,vol. 234, pp. 313- 322 ,(2001) , 10.1097/00000658-200109000-00005
Carlo Procacci, Giovanni Carbognin, Simone Accordini, Carlo Biasiutti, Alessandro Guarise, Frank Lombardo, Cristina Ghirardi, Rossella Graziani, Nicoletta Pagnotta, Roberto De Marco, CT features of malignant mucinous cystic tumors of the pancreas. European Radiology. ,vol. 11, pp. 1626- 1630 ,(2001) , 10.1007/S003300100855
R. Matthew Walsh, David P. Vogt, J. Michael Henderson, Gregory Zuccaro, John Vargo, John Dumot, Brian Herts, Charles V. Biscotti, Nancy Brown, Natural history of indeterminate pancreatic cysts. Surgery. ,vol. 138, pp. 665- 671 ,(2005) , 10.1016/J.SURG.2005.07.019
Jennifer F. Tseng, Andrew L. Warshaw, Dushyant V. Sahani, Gregory Y. Lauwers, David W. Rattner, Carlos Fernandez-del Castillo, Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment Annals of Surgery. ,vol. 242, pp. 413- 421 ,(2005) , 10.1097/01.SLA.0000179651.21193.2C
Peter J. Allen, Michael D??Angelica, Mithat Gonen, David P. Jaques, Daniel G. Coit, William R. Jarnagin, Ronald DeMatteo, Yuman Fong, Leslie H. Blumgart, Murray F. Brennan, A selective approach to the resection of cystic lesions of the pancreas: results from 539 consecutive patients. Annals of Surgery. ,vol. 244, pp. 572- 582 ,(2007) , 10.1097/01.SLA.0000237652.84466.54
Michael G Sarr, Michel Murr, Thomas C Smyrk, Charles J Yeo, Carlos Fernandez-del-Castillo, Robert H Hawes, Patrick C Freeny, Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions. Journal of Gastrointestinal Surgery. ,vol. 7, pp. 417- 428 ,(2003) , 10.1016/S1091-255X(02)00163-4
W. Meyer, J. Köhler, C. Gebhardt, Cystic neoplasms of the pancreas--cystadenomas and cystadenocarcinomas. Langenbeck's Archives of Surgery. ,vol. 384, pp. 44- 49 ,(1999) , 10.1007/S004230050172
Jeffrey M. Hardacre, Michael F. McGee, Thomas A. Stellato, James A. Schulak, An aggressive surgical approach is warranted in the management of cystic pancreatic neoplasms. American Journal of Surgery. ,vol. 193, pp. 374- 379 ,(2007) , 10.1016/J.AMJSURG.2006.09.029